February 25, 2015 - ZOLL to Display Expanded Resuscitation and Acute Critical Care Portfolio at EMS Today

CONTACT:

Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637
[email protected]

ZOLL TO DISPLAY EXPANDED RESUSCITATION AND ACUTE CRITICAL CARE PORTFOLIO AT EMS TODAY

Opportunity to Respond to a Simulated 911 Call with Road Safety’s Proactive Coaching

February 25, 2015─CHELMSFORD, MASS.— ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, will showcase its expanded portfolio of advanced CPR and acute critical care technologies, along with its integrated data solutions, in booths #404 and #2117 at EMS Today, February 26-28 in Baltimore.

Making its debut as part of the ZOLL family of products is the 731 Series of portable critical care ventilators, which ZOLL acquired from Impact Instrumentation, Inc. The rugged 731 Series ventilators are ideal for the ambulance transport of infants (≥5kg), pediatric patients, and adults and feature an unprecedented 10-hour battery life. Also new to the ZOLL portfolio, as a result of ZOLL’s acquisition of Advanced Circulatory Systems, Inc., is the ResQPOD® Impedance Threshold Device, which is used to enhance perfusion during CPR.

Unsurpassed CPR Support

ZOLL’s breakthrough CPR technologies, in conjunction with scenario-based training, have been shown to almost triple survival-to-hospital discharge with favorable neurological outcomes.1 This real-time CPR feedback technology reassures rescuers that their chest compressions are effective. With the CPR Dashboard featuring ZOLL’s Real CPR Help®, rescuers see numeric displays of CPR quality measures on the X Series® Monitor/Defibrillator that help to drive high-quality CPR. This dashboard provides real-time information on depth and rate, visual indicators of compression release, and a perfusion performance indicator. ZOLL recently announced its intent to expand the X Series interface to the Cardiac Arrest Registry to Enhance Survival (CARES) to include a full set of key CPR metrics.

As part of ZOLL’s long-time commitment to improving manual CPR, ZOLL makes Real CPR Help available on all AEDs and standard defibrillators the company ships. In addition to the X Series, this real-time CPR feedback technology is incorporated into the AED Plus®, the Fully Automatic AED Plus, and the AED Pro®.

Experience the ZOLL CPR Challenge

EMS Today attendees will have a chance to test their CPR skills with and without the benefit of Real CPR Help. Using ZOLL’s RescueNet® Code Review software, which provides complete CPR performance feedback, participants will see a detailed analysis of their CPR performance. Stethoscopes will be given to top performers each day.

Mechanical CPR at Any Angle with the AutoPulse

Attendees will have the opportunity to experience the ease with which patients can be moved using the AutoPulse® Non-invasive Cardiac Support Pump. Participants will maneuver a patient through a course of stairs and tight turns, while the AutoPulse performs continuous compressions.

The AutoPulse is the only mechanical CPR system to have shown improved outcomes in comparative clinical trials. In a meta-analysis of 12 comparative clinical trials, the AutoPulse improved the odds of return of spontaneous circulation (ROSC) by 62% compared to manual CPR.2 The CIRC trial, the largest prospective, randomized trial of mechanical chest compression ever completed, confirmed that the AutoPulse is equivalent to high-quality manual CPR for survival to hospital discharge.3

Advancing Care with Data-driven Solutions

Highlights from ZOLL’s data management suite of products include Road Safety®, a program for modifying driver behavior to improve safety and reduce vehicle maintenance costs. In booth #2117, attendees will have the opportunity to experience Road Safety’s proactive coaching as they respond to a simulated 911 call. Top drivers, graded on safety and response time, will be awarded prizes.

ZOLL’s RescueNet Suite for EMS and Fire is the only fully integrated information management system that touches the entire Chain of Survival from dispatch through discharge with the ability to improve clinical and operational performance. Key data-driven solutions on display from ZOLL include:

  • RescueNet ePCR Suite v6.0, now NEMSIS Version 3 compliant, for harmonizing EMS data with patient data in the hospital. With RescueNet Link, RescueNet ePCR is used for patient care documentation, quality assurance, and data transfer to expedite care.
  • RescueNet Dispatch for improved first response coordination using historical data and electronic communication.
  • RescueNet Billing for quick and accurate reimbursement of services.
  • RescueNet 12-Lead for sending and receiving 12-lead transmissions from any number of defibrillators and EMS services at no cost to the sender or receiver.
  • Insight Analytics for benchmarking and measuring performance to see where improvements can be made.

ZOLL Lunch and Learn: “What Does the Future of CPR Hold?”

Survival rates from out-of-hospital cardiac arrest have been historically dismal. Recent advances have started to move the needle on survival from cardiac arrest. Learn from Brent Parquette, EMT-P, Lucas County EMS in Toledo, Ohio, about what’s driving increased survival in EMS systems today and hear about cutting edge research that may indicate what CPR will look like in the future to drive further increases in survival. Registration fee is $10. Proceeds will be donated to the Foundation for International Emergency Medicine Education and Certification (F.I.E.R.C.E.). The session will be held on Friday, Feb. 27, 12:00-1:30 p.m., in Room 327/328.

About ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation. ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care. For more information, visit www.zoll.com.

About Asahi Kasei

The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 29,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.

©2015 ZOLL Medical Corporation. All rights reserved. Real CPR Help, See-Thru CPR, X Series, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All trademarks are the property of their respective owners.

1Bobrow BJ, et al. The Influence of Scenario-based Training and Real-time Audiovisual Feedback on Pre-hospital Cardiopulmonary Resuscitation Quality and Survival from Out-of-hospital Cardiac Arrest. Ann Emerg Med. 2013 Jul;62(1):47–56.e1. Epub 2013 Mar 7.

2Wesfall M, et al. Mechanical Vs. Manual Chest Compressions in Out-of-Hospital Cardiac Arrest: A Meta-Analysis. Crit Care Med. 2013 Jul;41(7):1782‐9.

3Wik L, et al. Manual vs. Integrated Automatic Load-distributing Band CPR with Equal Survival after Out- of- Hospital Cardiac Arrest. The Randomized CIRC Trial. Resuscitation 85 (2014) 741–748.